Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Stroke & Cerebrovascular Diseases

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jstrokecerebrovasdis.2013.04.001PMID 23727456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2015cited by this paper
• Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data

  2015cited by this paper
• Thrombolysis for acute ischaemic stroke.

  2014cited by this paper
• CANADIAN BEST PRACTICE RECOMMENDATIONS FOR STROKE CARE

  2013cited by this paper
• Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Effects of Public Education by Television on Knowledge of Early Stroke Symptoms Among a Japanese Population Aged 40 to 74 Years: A Controlled Study

  2012cited by this paper
• A Multicentre, Randomized, Double-Blinded, Placebo-Controlled Phase III Study to Investigate Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND)

  2012cited by this paper
• A New Support System Using a Mobile Device (Smartphone) for Diagnostic Image Display and Treatment of Stroke

  2012cited by this paper
• The Safety of Intravenous Thrombolysis for Ischemic Stroke in Patients With Pre-Existing Cerebral Aneurysms: A Case Series and Review of the Literature

  2012cited by this paper
• Too Good to Treat? Outcomes in Patients Not Receiving Thrombolysis Due to Mild Deficits or Rapidly Improving Symptoms

  2012cited by this paper
• Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

  2012cited by this paper
• Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.

  2012cited by this paper
• Reducing in-hospital delay to 20 minutes in stroke thrombolysis

  2012cited by this paper
• Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.

  2012cited by this paper
• Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial.

  2012cited by this paper
• Low-Dose Intravenous Recombinant Tissue-Type Plasminogen Activator Therapy for Patients With Stroke Outside European Indications: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rtPA Registry

  2012cited by this paper
• The natural course of unruptured cerebral aneurysms in a Japanese cohort.

  2012cited by this paper
• Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial.

  2012cited by this paper
• Safety of periprocedural heparin in acute ischemic stroke endovascular therapy: the multi MERCI trial.

  2012cited by this paper
• Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial.

  2012cited by this paper
• The Argatroban and tPA Stroke Study: final results of a pilot safety study

  2012cited by this paper
• A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.

  2012cited by this paper
• Carotid duplex ultrasonography can predict outcome of intravenous alteplase therapy for hyperacute stroke.

  2011cited by this paper
• Intravenous Thrombolysis Based on Diffusion-Weighted Imaging and Fluid-Attenuated Inversion Recovery Mismatch in Acute Stroke Patients with Unknown Onset Time

  2011cited by this paper
• 急性期脳梗塞に対するrt-PA静注療法後， 心破裂を併発した一剖検例

  2011cited by this paper
• Early Ischemic Change on CT Versus Diffusion-Weighted Imaging for Patients With Stroke Receiving Intravenous Recombinant Tissue-Type Plasminogen Activator Therapy: Stroke Acute Management With Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry

  2011cited by this paper
• Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).

  2011cited by this paper
• Intravenous thrombolytic therapy in patients with stroke mimics: baseline characteristics and safety profile

  2011cited by this paper
• Safety and Outcomes of Intravenous Thrombolysis in Stroke Mimics: A 6-Year, Single-Care Center Study and a Pooled Analysis of Reported Series

  2011cited by this paper
• Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator

  2011cited by this paper
• I. Stroke in general.

  2011cited by this paper
• Reconsidering recent myocardial infarction as a contraindication for IV stroke thrombolysis

  2011cited by this paper
• Effect of Baseline CT Scan Appearance and Time to Recanalization on Clinical Outcomes in Endovascular Thrombectomy of Acute Ischemic Strokes

  2011cited by this paper
• Clinical and MRI Predictors of No Early Recanalization Within 1 Hour After Tissue-Type Plasminogen Activator Administration

  2011cited by this paper
• Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80 years of age

  2011cited by this paper
• Intravenous Thrombolysis in Ischemic Stroke Patients with Intracranial Neoplasms: Two Cases and a Literature Review

  2011cited by this paper
• Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis

  2011cited by this paper
• Spotlight on the April 12 Issue

  2011cited by this paper
• Clinical Guidelines for Stroke Management 2010

  2010cited by this paper
• Part 14: Pediatric Advanced Life Support

  2010cited by this paper
• Strokes With Minor Symptoms: An Exploratory Analysis of the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trials

  2010cited by this paper
• Effects of 0.6 mg/kg Intravenous Alteplase on Vascular and Clinical Outcomes in Middle Cerebral Artery Occlusion: Japan Alteplase Clinical Trial II (J-ACT II)

  2010cited by this paper
• Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice: The Japan post-Marketing Alteplase Registration Study (J-MARS)

  2010cited by this paper
• Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive

  2010cited by this paper
• Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

  2010cited by this paper
• Thrombolysis Is Associated With Consistent Functional Improvement Across Baseline Stroke Severity: A Comparison of Outcomes in Patients From the Virtual International Stroke Trials Archive (VISTA)

  2010cited by this paper
• Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2010cited by this paper
• Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA

  2010cited by this paper
• Hyper-acute stroke patients associated with aortic dissection.

  2010cited by this paper
• The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe

  2010cited by this paper
• Endovascular Thrombectomy for Acute Ischemic Stroke in Failed Intravenous Tissue Plasminogen Activator Versus Non–Intravenous Tissue Plasminogen Activator Patients: Revascularization and Outcomes Stratified by the Site of Arterial Occlusions

  2010cited by this paper
• Residual Vessel Length on Magnetic Resonance Angiography Identifies Poor Responders to Alteplase in Acute Middle Cerebral Artery Occlusion Patients: Exploratory Analysis of the Japan Alteplase Clinical Trial II

  2010cited by this paper
• rt-PA(アルテプラーゼ)静注療法の承認後4年間の全国における実施状況調査～地域格差の克服に向けて～

  2010cited by this paper
• Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2010cited by this paper
• M1 Susceptibility Vessel Sign on T2* as a Strong Predictor for No Early Recanalization After IV-t-PA in Acute Ischemic Stroke

  2009cited by this paper
• Relationship of Blood Pressure, Antihypertensive Therapy, and Outcome in Ischemic Stroke Treated With Intravenous Thrombolysis: Retrospective Analysis From Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR)

  2009cited by this paper
• Early Recanalization Rate of Major Occluded Brain Arteries after Intravenous Tissue Plasminogen Activator Therapy Using Serial Magnetic Resonance Angiography Studies

  2009cited by this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009).

  2009cited by this paper
• The Penumbra Pivotal Stroke Trial: Safety and Effectiveness of a New Generation of Mechanical Devices for Clot Removal in Intracranial Large Vessel Occlusive Disease

  2009cited by this paper
• Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association.

  2009cited by this paper
• Impact of the Approval of Intravenous Recombinant Tissue Plasminogen Activator Therapy on the Processes of Acute Stroke Management in Japan: The Stroke Unit Multicenter Observational (SUMO) Study

  2009cited by this paper
• Increasing number of stroke specialists should contribute to utilization of IV rt-PA: results of questionnaires from 1,466 hospitals in Japan.

  2009cited by this paper
• Arterial Occlusion Sites on Magnetic Resonance Angiography Influence the Efficacy of Intravenous Low-Dose (0·6 mg/kg) Alteplase Therapy for Ischaemic Stroke

  2009cited by this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)

  2009cited by this paper
• Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese Patients: General Outcomes and Prognostic Factors From the SAMURAI Register

  2009cited by this paper
• Negative fluid‐attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less

  2009cited by this paper
• Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

  2009cited by this paper
• The Number of Stroke Physicians Is the Key to Preparing IV rt-PA

  2009cited by this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2

  2009cited by this paper
• Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

  2009cited by this paper
• Thrombolysis for ischaemic stroke and glioblastoma multiforme: a case report

  2009cited by this paper
• Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study.

  2008cited by this paper
• Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST)

  2008cited by this paper
• Large Ischemic Lesions on Diffusion-Weighted Imaging Done Before Intravenous Tissue Plasminogen Activator Thrombolysis Predicts a Poor Outcome in Patients With Acute Stroke

  2008cited by this paper
• Addressing Stroke Signs and Symptoms Through Public Education: The Stroke Heroes Act FAST Campaign

  2008cited by this paper
• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• Is it appropriate to exclude patients with unruptured intracranial aneurysms from the indication for intravenous thrombolysis with rt-PA for acute cerebral infarction?

  2008cited by this paper
• Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.

  2008cited by this paper
• Sonothrombolysis With Transcranial Color-Coded Sonography and Recombinant Tissue-Type Plasminogen Activator in Acute Middle Cerebral Artery Main Stem Occlusion: Results From a Randomized Study

  2008cited by this paper
• Guidelines for management of ischaemic stroke and transient ischaemic attack 2008.

  2008cited by this paper
• Association of Characteristics of Blood Pressure Profiles and Stroke Outcomes in the ECASS-II Trial

  2008cited by this paper
• Kurashiki Prehospital Stroke Scale

  2008cited by this paper
• Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial

  2008cited by this paper
• Guidelines for the Early Management of Adults With Ischemic Stroke

  2007cited by this paper
• Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke

  2007cited by this paper
• MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows: An Analysis of 1210 Patients

  2007cited by this paper
• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

  2007cited by this paper
• IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study.

  2007cited by this paper
• Standardizing display conditions of diffusion-weighted images using concurrent b0 images: a multi-vendor multi-institutional study.

  2007cited by this paper
• The Interventional Management of Stroke (IMS) II Study

  2007cited by this paper
• The Interventional Management of Stroke (IMS) II Study.

  2007cited by this paper
• Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan

  2007cited by this paper
• Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled Analysis of T2*-Weighted Magnetic Resonance Imaging Data From 570 Patients

  2007cited by this paper
• Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset: Japan Alteplase Clinical Trial (J-ACT)

  2006cited by this paper
• Extent of Early Ischemic Changes on Computed Tomography (CT) Before Thrombolysis: Prognostic Value of the Alberta Stroke Program Early CT Score in ECASS II

  2006cited by this paper
• Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study

  2006cited by this paper
• Early MRI and outcomes of untreated patients with mild or improving ischemic stroke

  2006cited by this paper
• Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion: An Independent Predictor of Poor Outcome After Systemic Thrombolysis

  2006cited by this paper
• Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers: The Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany

  2006cited by this paper
• Presence of Early Ischemic Changes on Computed Tomography Depends on Severity and the Duration of Hypoperfusion: A Single Photon Emission–Computed Tomographic Study

  2005cited by this paper

• Analysis of hemorrhagic transformation and intracerebral hemorrhage under combination therapy with alteplase and antiplatelets or anticoagulants, using the Japanese Adverse Drug Event Report database

  2025influential citation
• Development of tenecteplase for stroke thrombolysis: Japan's endeavor.

  2025cites this paper
• Edaravone's Safety Profile in Acute Ischemic Stroke

  2024cites this paper
• Multicenter Exploration of Tenecteplase Transition Factors: A Quantitative Analysis.

  2024cites this paper
• Intracranial atherosclerotic disease mechanism indicates poor outcomes of thrombectomy in acute cerebral infarction with large vessel occlusion: A matched cohort study.

  2024cites this paper
• Incidental Findings on Whole-Body Computed Tomography Angiography in Patients With Suspected Acute Stroke

  2024cites this paper
• Therapeutic management of ischemic stroke

  2023cites this paper
• A qualitative study of barriers and facilitators to using tenecteplase to treat acute ischemic stroke.

  2023cites this paper
• Effect of edaravone on symptomatic intracranial hemorrhage in patients with acute large vessel occlusion on apixaban for non-valvular atrial fibrillation.

  2023cites this paper
• Improvement of Functional Outcomes in Patients with Stroke who Received Alteplase for Over 15 Years: Japan Stroke Data Bank

  2023cites this paper
• Effectiveness and safety of the Trevo® Retriever for mechanical thrombectomy in Chinese patients with acute ischemic stroke: Trevo Retriever China Registry

  2023cites this paper
• A systematic review and synthesis of global stroke guidelines on behalf of the World Stroke Organization

  2023cites this paper
• Safety of Apixaban Monotherapy for Non-Valvular Atrial Fibrillation-Related Acute Stroke with Intra-/Extracranial Artery Stenosis

  2022cites this paper
• Possible Contribution of the Aspiration Catheter in Preventing Post-stent Retriever Thrombectomy Subarachnoid Hemorrhage

  2022cites this paper
• The reperfusion therapy brings apixaban administration forward in nonvalvular arterial fibrillation patients with anterior circulation large vessel occlusion or stenosis.

  2022cites this paper
• Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial

  2022cites this paper
• Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3–4.5 h

  2022cites this paper
• Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review

  2022cites this paper
• Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants

  2022cites this paper
• Delays in Presentation Time Under the COVID-19 Epidemic in Patients With Transient Ischemic Attack and Mild Stroke: A Retrospective Study of Three Hospitals in a Japanese Prefecture

  2021cites this paper
• Thrombolysis in acute ischaemic stroke patients with chronic kidney disease

  2021cites this paper
• Endovascular Therapy for Acute Ischemic Stroke in Patients With Prestroke Disability

  2021cites this paper
• Histopathological analysis of retrieved thrombi from patients with acute ischemic stroke with malignant tumors

  2021cites this paper
• Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence

  2021cites this paper
• Simultaneous cardio-cerebral embolization associated with atrial �brillation: a case report

  2021cites this paper
• Simultaneous cardio-cerebral embolization due to atrial �brillation: a case report

  2021cites this paper
• Risk factors for acute ischemic stroke following intravenous thrombolysis: a 2-center retrospective cohort study.

  2021cites this paper
• Short-Vessel Occlusion Might Indicate Higher Possibility of Success in Reperfusion following Mechanical Thrombectomy in Acute Middle Cerebral Artery Occlusion

  2021cites this paper
• Screening risk factors of intravenous thrombolysis for acute ischemic stroke : A multicenter retrospective cohort study

  2021cites this paper
• Quality of stroke guidelines in low- and middle-income countries: a systematic review

  2021cites this paper
• Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset

  2020cites this paper
• Therapeutics targeting the fibrinolytic system

  2020cites this paper
• Trends in Endovascular Reperfusion Therapy for Acute Stroke after Introduction of Mechanical Thrombectomy Devices: Japanese Registry of NeuroEndovascular Therapy (JR-NET)3

  2020cites this paper
• Safety of Early Administration of Apixaban on Clinical Outcomes in Patients with Acute Large Vessel Occlusion

  2020cites this paper
• Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke

  2020cites this paper
• Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan.

  2020cites this paper
• Magnetic Resonance Imaging–Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size

  2020cites this paper
• Diffusion-Weighted Imaging-Fluid-Attenuated Inversion Recovery Mismatch Is Associated with 90-Day Functional Outcomes in Patients Undergoing Mechanical Thrombectomy

  2020cites this paper
• Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances

  2020cites this paper
• Endovascular therapy for hemodialysis patients with atrial fibrillation and cerebral thromboembolism: A case series

  2020cites this paper
• Clinical features and efficacy of reperfusion therapy in minor ischemic stroke patients with atrial fibrillation

  2020cites this paper
• Controversies in cerebrovascular disease: high or low doses of recombinant tissue plasminogen activator to treat acute stroke? A literature review.

  2020cites this paper
• Feasibility and efficacy of a 9-Fr balloon-guiding catheter sheathless insertion to reduce access site complications during mechanical thrombectomy for acute ischemic stroke.

  2020cites this paper
• Small Peptides as Modulators of Serine Proteases.

  2020cites this paper
• Clinical Outcome of Patients With Large Vessel Occlusion and Low National Institutes of Health Stroke Scale Scores

  2020cites this paper
• Small but Steady Steps in Stroke Medicine in Japan

  2019cites this paper
• Intravenous Thrombolysis Administration 3–4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study

  2019cites this paper
• Use of Diffusion‐Weighted Imaging‐Alberta Stroke Program Early Computed Tomography Score (DWI‐ASPECTS) and Ischemic Core Volume to Determine the Malignant Profile in Acute Stroke

  2019cites this paper
• Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis

  2019cites this paper
• Clinical Performance Measures for Neurocritical Care: A Statement for Healthcare Professionals from the Neurocritical Care Society

  2019cites this paper
• Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society

  2019cites this paper
• Repeated mechanical thrombectomy for acute ischemic stroke in a dialysis patient: A case report and literature review

  2019cites this paper
• Differences between predictive factors for early neurological deterioration due to hemorrhagic and ischemic insults following intravenous recombinant tissue plasminogen activator

  2019cites this paper
• Repeated Mechanical Thrombectomy of Recurrent Large Vessel Occlusion: Case Report and Brief Review of the Literature

  2019cites this paper
• Simultaneous cardio-cerebral embolization due to atrial fibrillation: a case report

  2019cites this paper
• Uneventful Pregnancy and Delivery after Thrombolysis Plus Thrombectomy for Acute Ischemic Stroke: Case Study and Literature Review.

  2019cites this paper
• Catastrophic Secondary Infarctions with Onset Seizure Following Tissue Plasminogen Activator Therapy.

  2019cites this paper
• Utility of Minimum Apparent Diffusion Coefficient Ratios in Alberta Stroke Program Early CT Score Regions for Deciding on Stroke Therapy.

  2019cites this paper
• Dual-Energy Computed Tomography for Evaluating Acute Brain Infarction of Middle Cerebral Artery Territories: Optimization of Voltage Settings in Virtual Monoenergetic Imaging.

  2019cites this paper
• Detrimental Effect of Chronic Hypertension on Leptomeningeal Collateral Flow in Acute Ischemic Stroke.

  2019cites this paper
• Hyperperfusion Immediately after Reperfusion by Thrombectomy May Predict Hemorrhagic Transformation

  2019cites this paper
• Phased changes in strategies can reduce delay of intravenous thrombolysis administration to 15 min.

  2019cites this paper
• Cost Effectiveness of Drive and Retrieve System in Hokkaido for Acute Ischemic Stroke Patient Treatment Using Geographic Information System.

  2019cites this paper
• Low-dose versus standard-dose alteplase in acute ischemic stroke in Asian stroke registries: an individual patient data pooling study

  2019cites this paper
• Simultaneous cardio-cerebral embolization associated with atrial fibrillation: a case report

  2019cites this paper
• Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.

  2019cites this paper
• Onset to Reperfusion Time Was Not Important in Mechanical Thrombectomy for Elderly Patients: A Retrospective Multicenter Study in Tama Area, Tokyo

  2018cites this paper
• Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis

  2018cites this paper
• Consensus Guides on Stroke Thrombolysis for Anticoagulated Patients from Japan: Application to Other Populations

  2018cites this paper
• Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials

  2018cites this paper
• Urgent Detection of Acute Type A Aortic Dissection in Hyperacute Ischemic Stroke or Transient Ischemic Attack.

  2018cites this paper
• Successful Tissue Plasminogen Activator for a Patient with Stroke After Stanford Type A Aortic Dissection Treatment.

  2018cites this paper
• Cerebrovascular imaging of cerebral ischemia in acute type A aortic dissection.

  2018cites this paper
• Seasonal Variations in Neurological Severity and Outcomes of Ischemic Stroke　- 5-Year Single-Center Observational Study.

  2018cites this paper
• Initial Attempt to Select Patients for Mechanical Thrombectomy Using Noncontrast Computed Tomography and Symptom-Based Criteria: Single-Center Experience.

  2018cites this paper
• [Thrombolytic therapy of ischemic stroke].

  2018cites this paper
• Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review

  2018cites this paper
• N1-Nonyl-1,4-diaminobutane ameliorates brain infarction size in photochemically induced thrombosis model mice.

  2018cites this paper
• Safety of urgent STA-MCA anastomosis after intravenous rt-PA treatment: a report of five cases and literature review

  2018cites this paper
• Acute pancreatitis is a very rare comorbidity of acute ischemic stroke

  2018cites this paper
• Why not Intravenous Thrombolysis in Patients with Recurrent Stroke within 3 Months?

  2018cites this paper
• Controversies in cerebrovascular disease: High or low doses of recombinant tissue plasminogen activator to treat acute stroke? A literature review.

  2018cites this paper
• Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.

  2018cites this paper
• The JAGUAR Score Predicts 1-Month Disability/Death in Ischemic Stroke Patient Ineligible for Recanalization Therapy.

  2018cites this paper
• A case of cerebral infarction during a hemodialysis procedure successfully treated with recombinant tissue plasminogen activator

  2018cites this paper
• Acute ischemic stroke as a complication of Stanford type A acute aortic dissection: a review and proposed clinical recommendations for urgent diagnosis

  2018cites this paper
• In Hyperacute Recanalization Therapy, Early Hospital Arrival Improves Outcome in Patients with Large Artery Occlusion

  2018cites this paper
• Vascular wall components in thrombi obtained by acute stroke thrombectomy: clinical significance and related factors

  2018cites this paper
• Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.

  2017cites this paper
• Derivation and Validation of a Scoring System for Intravenous Tissue Plasminogen Activator Use in Asian Patients.

  2017cites this paper
• Successful Delayed Aortic Surgery for a Patient with Ischemic Stroke Secondary to Aortic Dissection

  2017cites this paper
• Clinical Study of Intravenous, Low-Dose Recombinant Tissue Plasminogen Activator for Acute Cerebral Infarction: Comparison of Treatment within 3 Hours versus 3-4.5 Hours.

  2017cites this paper
• Low risk of ICH after reperfusion therapy in acute stroke patients treated with direct oral anti-coagulant.

  2017cites this paper
• Thrombolysis-related Multiple Lobar Hemorrhaging in Cerebral Amyloid Angiopathy with Extensive Strictly Lobar Cerebral Microbleeding

  2017cites this paper
• Clinical characteristics of type A acute aortic dissection with CNS symptom

  2017cites this paper
• Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).

  2017cites this paper
• Three Stages of Evolution in the Treatment of Acute Ischemic Stroke: Stroke Unit Care, Intravenous Thrombolysis and Endovascular Therapy

  2017cites this paper
• Evaluation of the CT High-density Area after Endovascular Treatment for Acute Ischemic Stroke

  2017cites this paper
• Intravenous Thrombolysis for Acute Ischemic Stroke

  2017cites this paper
• Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2016cites this paper